Investigated
Can inhibiting this age-related protein reliably regenerate human knee cartilage and prevent osteoarthritis?
Short answer
Image: med.stanford.edu
Blocking 15-PGDH regenerated cartilage and improved joint outcomes in aged or injured mice, while treated human cartilage samples produced new tissue in laboratory studies. That is promising biology, not proof of a reliable human therapy: no source reports a completed clinical trial showing that patients avoided osteoarthritis or knee replacement.
The views on this question
Two lenses on the same evidence. Source weight and the primary source ratio show what each rests on.
Skeptics
Source weight 40%The cautious interpretation emphasizes the gap between laboratory regeneration and clinical benefit. Mice and excised tissue cannot establish whether a treatment reaches diseased human joints safely, produces durable load-bearing cartilage, relieves pain, or prevents replacement surgery. Promotional claims about making knee replacement unnecessary therefore remain hypotheses rather than demonstrated outcomes.
- No patient has yet been shown to avoid knee replacement because of this therapy.
- Human evidence consists of ex vivo tissue samples, not treatment of people with osteoarthritis.
- Mouse improvements in cartilage appearance, movement, or weight-bearing do not by themselves establish reliable human pain relief or long-term disease prevention.
- Claims that the approach could render joint replacement unnecessary describe a possible future application, not a demonstrated clinical result.